Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-15

Clinical Trial Update: Efficacy and Safety of Two Simeticone Brands in Adults With Functional Dyspepsia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of two simeticone brands in adults with Functional Dyspepsia has completed, reporting results on symptom reli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Simeticone Brand A (simeticone)
  • Simeticone Brand B (simeticone)

Snippet

Sponsor: Johnson & Johnson Consumer and Personal Products Worldwide | Conditions: Functional Dyspepsia | Phase 3 | Status: COMPLETED